Skip to content
Open access · CC-BY via OpenAlex

Alpha-Synuclein and Cognitive Decline in Parkinson Disease

Tian-Sin Fan, Sam Chi-Hao Liu, Ruey‐Meei Wu

Life · 2021 · ▲ 44 citations

Abstract

Parkinson disease (PD) is the second most common neurodegenerative disorder in elderly people. It is characterized by the aggregation of misfolded alpha-synuclein throughout the nervous system. Aside from cardinal motor symptoms, cognitive impairment is one of the most disabling non-motor symptoms that occurs during the progression of the disease. The accumulation and spreading of alpha-synuclein pathology from the brainstem to limbic and neocortical structures is correlated with emerging cognitive decline in PD. This review summarizes the genetic and pathophysiologic relationship between alpha-synuclein and cognitive impairment in PD, together with potential areas of biomarker advancement.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/life11111239
Canonical
link ↗
Fetched
2026-10-21 MST

Cite this

APA
Fan, T., Liu, S.C., &amp; Wu, R. (2021). Alpha-Synuclein and Cognitive Decline in Parkinson Disease. <em>Life</em>. https://doi.org/10.3390/life11111239
Vancouver
Fan T, Liu SC, Wu R. Alpha-Synuclein and Cognitive Decline in Parkinson Disease. Life. 2021. doi:10.3390/life11111239.
BibTeX
@article{tiansin2021AlphaS, title = {Alpha-Synuclein and Cognitive Decline in Parkinson Disease}, author = {Tian-Sin Fan and Sam Chi-Hao Liu and Ruey‐Meei Wu}, journal = {Life}, year = {2021}, doi = {10.3390/life11111239}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings